Carolina and the Gene Editing Institute introduce Nobel Prize-winning technology and STEM 2023 Awards Finalist kit to give students hands-on, cutting-edge lab experience of cell-free gene editing.
Eric Kmiec, Ph.D., executive director and chief scientific officer of ChristianaCare’s Gene Editing Institute, has been selected as editor-in-chief of the scientific journal Gene and Genome Editing. Kmiec served three years on the journal’s board prior to this new position.
Hewes was among honorees at a special event held at Delaware Legislative Hall
Gene Editing Institute opens special learning lab on STAR Campus offering free experiences with revolutionary technology
Gene Editing Institute scientists travel to North Carolina to teach workshops and bring CRISPR gene editing to high school students from diverse backgrounds
In a new study in journal Gene Therapy, researchers at ChristianaCare’s Gene Editing Institute describe how the advance is validating the safety and efficacy of their novel approach for using CRISPR to improve lung cancer treatments
Students at Salem Academy first to learn with the innovative tool in North Carolina as interest grows nationwide
CRISPR in a Box Educational Toolkit™ – a gene editing experiment developed by the Gene Editing Institute for teaching – and the videos are already being used in classrooms in Delaware; Goal to reach students of color
Toolkit is easily incorporated into any laboratory science course
Study in The CRISPR Journal from ChristianaCare’s Gene Editing Institute reports the app advances CRISPR gene therapy R&D; 18-year-old software savant helped lead the app’s development
$1 million grant will advance personalized medicine using gene editing at ChristianaCare’s Gene Editing Institute
Study in Communications Biology-Nature from ChristianaCare’s Gene Editing Institute debuts new method that unmasks all DNA changes caused by CRISPR in two days vs. two months; most errant edits may be harmless, but insights essential to gauge patient risks
Gene Editing Institute’s study will be a novel investigation of the use of CRISPR technology to treat K-ras-positive non-small cell lung cancer
Technology from The Gene Editing Institute licensed to biotech firm NovellusDx to drive next-generation personalized cancer care
Biotechnology expert Byung-Chun Yoo, Ph.D., has been appointed associate director of Christiana Care Health System’s Gene Editing Institute of the Helen F. Graham Cancer Center & Research Institute. Dr. Yoo brings more than 18 years of experience leading projects in genome editing, advanced molecular biology and biochemistry to this position
ChristianaCare and Delaware BioScience Association event explores new FDA Guidances and other challenges and opportunities in gene editing
New study from Gene Editing Institute at Delaware’s Christiana Care Health System embodies cautious, patient-focused approach to cutting-edge tool
Christiana Care Health System and Delaware Biotechnology Association Symposium Opens Dialogue about CRISPR
The new award was created to recognize a company, researcher or individual in the tri-state area that has the potential to make a significant impact on health care
Delaware’s Gene Editing Institute Discovery Could Rapidly Advance Personalized Cancer Care
The NSF Advanced Technical Education (ATE) grant will support development of a gene editing curriculum for community college students
Molecular biologists at Christiana Care Health System's Gene Editing Institute have developed a new system that allows them to not only repair damaged DNA within human cells, but also to determine when the DNA repair machinery has introduced unwanted genetic changes alongside, or instead of, the desired repair
Partnership with NovellusDx for research in the development of new gene editing technologies that can lead to personalized cancer therapies
Molecular biologists at Christiana Care Health System's Gene Editing Institute have developed a new system that allows them to not only repair damaged DNA within human cells
Genetic researchers at Christiana Care Health System’s Gene Editing Institute have demonstrated that short pieces of synthetic single-stranded DNA when used in gene editing with the CRISPR/Cas9 technique, can promote the repair of genetic mutations, help achieve a cleaner “cut” of the gene, and reduce the degree of genetic fraying
To accelerate breakthrough cancer research in the human genome, the Gene Editing Institute at Christiana Care’s Helen F. Graham Cancer Center & Research Institute has entered into an agreement with The Wistar Institute